Labroots: ACE CancerPlus Test for DNA & RNA Sequencing for Improved Patient Outcomes

Oncologists and pathologists are increasingly utilizing information on genomic alterations in tumors to help guide patient care and treatment. Personalis, Inc., a genomic sequencing and interpretation company, has developed a tumor-profiling test that provides clinicians with accurate and comprehensive analysis and clinical reporting of 181 genes to guide treatment decisions.

Please accept preferences, statistics, marketing cookies to watch this video.
2018-08-06T08:47:25+00:00